GSK2256098 is a synthetic small-molecule compound investigated as a focal adhesion kinase inhibitor, currently under clinical evaluation for progressive meningiomas. It is available as a pharmaceutical raw material for research and manufacturing purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1224887-10-8
Protriptyline hydrochloride
pharmaceutical raw material
Faropenem sodium
pharmaceutical raw material
Omarigliptin
pharmaceutical raw material
Seractide
pharmaceutical raw material
2-[[5-chloro-2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)amino]-4-pyridinyl]amino]-N-methoxybenzamide
BVAHPPKGOOJSPU-UHFFFAOYSA-N
CC1=NN(C(=C1)NC2=NC=C(C(=C2)NC3=CC=CC=C3C(=O)NOC)Cl)C(C)C